| 2011 | | Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy. | 강석윤, 김장희, 박준성, 신승수, 안미선, 이광재, 이현우, 정성현, 최진혁, 한재호 |
| 2018 | | Blood eosinophil count as a prognostic biomarker in COPD | 박주헌, 이규성, 황성철 |
| 2022 | | Clinical findings, viral load, and outcomes of COVID-19: Comparison of patients with negative and positive initial chest computed tomography | 김은진, 신승수 |
| 2014 | | Consideration of additional factors in Sequential Organ Failure Assessment score. | 박광주, 박래웅, 박주헌, 신승수, 이규성, 정우영, 정윤정 |
| 1997 | | Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma. | 이이형 |
| 2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2014 | | Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD. | 박주헌, 신승수 |
| 2013 | | Exertional desaturation as a predictor of rapid lung function decline in COPD. | 신승수 |
| 2006 | | Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. | 박광주, 박래웅, 박주헌, 신승수, 오윤정, 이규성, 최영화, 황성철 |
| 2012 | | Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection | 강석윤, 김영배, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최진혁, 한상욱, 한재호 |
| 2020 | | Impact of Body Mass Index Change on the Prognosis of Chronic Obstructive Pulmonary Disease | 박범희, 박주헌 |
| 2021 | | Interferon-γ-inducible chemokines as prognostic markers for lung cancer | 박광주, 박주헌, 박지은, 신승수, 이규성, 정우영, 정윤정 |
| 2007 | | Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. | 강석윤, 강승희, 김장희, 김효철, 박준성, 신승수, 오영택, 이광재, 이현우, 전미선, 최진혁, 한재호 |
| 2012 | | Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases | 김보영, 김세혁, 김영배, 김장희, 신승수, 이기범, 이현우, 정선용, 한재호 |
| 2015 | | Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer. | 박광주, 박성용, 윤준기, 이수진 |
| 2011 | | Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease. | 신승수 |
| 2007 | | Serum angiopoietin-2 as a clinical marker for lung cancer. | 박광주, 박주헌, 신승수, 오윤정, 이규성, 황성철 |
| 2023 | | The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease | 박주헌, 박지원 |
| 2015 | | The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease. | 강대용, 박주헌, 신승수, 이규성 |
| 2021 | | Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data | 강석윤, 김태환, 신승수, 안미선, 이현우, 조헌도, 최용원, 최진혁 |
| 2001 | | Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts. | 강승희, 김현수, 김효철, 남동기, 박광주, 오영택, 이이형, 임호영, 전미선, 최진혁, 황성철 |
